title: Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients.
authors.forename: Raija
authors.initials: R
authors.lastname: Silvennoinen
authors.forename: Veli
authors.initials: V
authors.lastname: Kairisto
authors.forename: Tarja-Terttu
authors.initials: TT
authors.lastname: Pelliniemi
authors.forename: Mervi
authors.initials: M
authors.lastname: Putkonen
authors.forename: Pekka
authors.initials: P
authors.lastname: Anttila
authors.forename: Marjaana
authors.initials: M
authors.lastname: Säily
authors.forename: Anu
authors.initials: A
authors.lastname: Sikiö
authors.forename: Jorma
authors.initials: J
authors.lastname: Opas
authors.forename: Karri
authors.initials: K
authors.lastname: Penttilä
authors.forename: Taru
authors.initials: T
authors.lastname: Kuittinen
authors.forename: Tuomo
authors.initials: T
authors.lastname: Honkanen
authors.forename: Tuija
authors.initials: T
authors.lastname: Lundán
authors.forename: Vesa
authors.initials: V
authors.lastname: Juvonen
authors.forename: Tiina
authors.initials: T
authors.lastname: Luukkaala
authors.forename: Kari
authors.initials: K
authors.lastname: Remes
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D003131:Combined Modality Therapy / Q000379:methods; D003907:Dexamethasone / Q000008:administration & dosage; D018572:Disease-Free Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D011446:Prospective Studies; D011719:Pyrazines / Q000008:administration & dosage; D012074:Remission Induction; D014182:Transplantation, Autologous; D055815:Young Adult
chemical_list: D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone